Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Last Updated: 04/25/16

Code of Federal Regulations

Title 21

  • Part 50: Protection of Human Subjects
  • Part 56: Institutional Review Boards
  • Part 58: GLP’s
  • Parts 210-211: GMP’s
  • Part 312: INDs
  • Part 314: Approval Applications
  • Part 600 : Biological Products

About the Branch Chief

Jan Casadei, PhD Jan Casadei, PhD joined the National Cancer Institute in 1991, where she is now chief of the Regulatory Affairs Branch, CTEP. Her area of expertise covers FDA regulations, policies and guidelines for the conduct of clinical studies with investigational agents. As the chief of the Regulatory Affairs Branch, Dr. Casadei is responsible for facilitating the development of promising investigational anti-cancer agents, by providing regulatory/IND support More…